10636.  Albillos A, de-la-Hera A, Alvarez-Mon M. Serum lipopolysaccharide-binding protein prediction of severe bacterial infection in cirrhotic patients with ascites. Lancet. 2004 May 15;363(9421):1608-10.

10637.  Allaouchiche B, Boselli E. Soluble TREM-1 and the diagnosis of pneumonia. N Engl J Med. 2004 Apr 29;350(18):1904-5.

10638.  Almirall J, Bolibar I, Toran P, Pera G, Boquet X, Balanzo X, Sauca G; Community-Acquired Pneumonia Maresme Study Group. Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia. Chest. 2004 Apr;125(4):1335-42.

10639.  Alves DW, Kennedy MT. Community-acquired pneumonia in casualty: etiology, clinical features, diagnosis, and management (or a look at the "new" in pneumonia since 2002). Curr Opin Pulm Med. 2004 May;10(3):166-70. Review.

10640.  Aviram G, Boiselle PM. Imaging features of bacterial respiratory infections in AIDS. Curr Opin Pulm Med. 2004 May;10(3):183-8. Review.

10641.  Aziz ZA, Wells AU, Hansell DM, Bain GA, Copley SJ, Desai SR, Ellis SM, Gleeson FV, Grubnic S, Nicholson AG, Padley SP, Pointon KS, Reynolds JH, Robertson RJ, Rubens MB. HRCT diagnosis of diffuse parenchymal lung disease: inter-observer variation. Thorax. 2004 Jun;59(6):506-11.

10642.  Croce MA, Fabian TC, Mueller EW, Maish GO 3rd, Cox JC, Bee TK, Boucher BA, Wood GC. The appropriate diagnostic threshold for ventilator-associated pneumonia using quantitative cultures. J Trauma. 2004 May;56(5):931-4; discussion 934-6.

10643.  Ewig S, de Roux A, Bauer T, Garcia E, Mensa J, Niederman M, Torres A.  Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax. 2004 May;59(5):421-7.

10644.  Flanders SA, Stein J, Shochat G, Sellers K, Holland M, Maselli J, Drew WL, Reingold AL, Gonzales R. Performance of a bedside C-reactive protein test in the diagnosis of community-acquired pneumonia in adults with acute cough. Am J Med. 2004 Apr 15;116(8):529-35.

10645.  Georges H, Leroy O, Guery B. Soluble TREM-1 and the diagnosis of pneumonia. N Engl J Med. 2004 Apr 29;350(18):1904-5.

10646.  Larsen HH, Huang L, Kovacs JA, Crothers K, Silcott VA, Morris A, Turner JR, Beard CB, Masur H, Fischer SH. A prospective, blinded study of quantitative touch-down polymerase chain reaction using oral-wash samples for diagnosis of Pneumocystis pneumonia in HIV-infected patients. J Infect Dis. 2004 May 1;189(9):1679-83.

10647.  Luna CM. C-reactive protein in pneumonia: let me try again. Chest. 2004 Apr;125(4):1192-5.

10648.  Mejias A, Chavez-Bueno S, Rios AM, Saavedra-Lozano J, Fonseca Aten M, Hatfield J, Kapur P, Gomez AM, Jafri HS, Ramilo O. Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model. Antimicrob Agents Chemother. 2004 May;48(5):1811-22.

10649.  Nicholson AG, Addis BJ, Bharucha H, Clelland CA, Corrin B, Gibbs AR, Hasleton PS, Kerr KM, Ibrahim NB, Stewart S, Wallace WA, Wells AU.  Inter-observer variation between pathologists in diffuse parenchymal lung disease. Thorax. 2004 Jun;59(6):500-5.

10650.  Ruggeberg JU, Ketteler K, MacKenzie CR, Von Kries R, Reinert RR, Schroten H. Blood culture sampling rates at a German pediatric university hospital and incidence of invasive pneumococcal disease. Infection. 2004 Apr;32(2):78-81.

10651.  Saito K, Nakayamada S, Nakano K, Tokunaga M, Tsujimura S, Nakatsuka K, Adachi T, Tanaka Y. Detection of Pneumocystis carinii by DNA amplification in patients with connective tissue diseases: re-evaluation of clinical features of P. carinii pneumonia in rheumatic diseases. Rheumatology (Oxford). 2004 Apr;43(4):479-85.

10652.  Tuuminen T, Edelstein I, Punin A, Kislova N, Stratchounski L. Use of quantitative and objective enzyme immunoassays to investigate the possible association between Chlamydia pneumoniae and Mycoplasma pneumoniae antibodies and asthma. Clin Microbiol Infect. 2004 Apr;10(4):345-8.

10653.  Vijay D; Vijay Prakash Kumar GM. Chlamydia trachomatis serology in fertility and abortion cases: preliminary study. Antiseptic. 2004 Jan; 101(1): 9

Pathogenesis:

10654.  Agusti C, Torres A. Dying from pneumonia: what gene is the culprit? Crit Care Med. 2004 May;32(5):1225-6. Review.

10655.   Chow KC, Hsiao CH, Lin TY, Chen CL, Chiou SH. Detection of severe acute respiratory syndrome-associated coronavirus in pneumocytes of the lung. Am J Clin Pathol. 2004 Apr;121(4):574-80.

10656.  Groneberg DA, Witt H, Adcock IM, Hansen G, Springer J. Smads as intracellular mediators of airway inflammation. Exp Lung Res. 2004 Apr-May;30(3):223-50. Review.

10657.  Hedberg CL, Adcock K, Martin J, Loggins J, Kruger TE, Baier RJ. Tumor necrosis factor alpha -- 308 polymorphism associated with increased sepsis mortality in ventilated very low birth weight infants. Pediatr Infect Dis J. 2004 May;23(5):424-8.

10658.  Ibrahim YM, Kerr AR, McCluskey J, Mitchell TJ. Role of HtrA in the virulence and competence of Streptococcus pneumoniae. Infect Immun. 2004 Jun;72(6):3584-91.

10659.  Jakubzick C, Choi ES, Carpenter KJ, Kunkel SL, Evanoff H, Martinez FJ, Flaherty KR, Toews GB, Colby TV, Travis WD, Joshi BH, Puri RK, Hogaboam CM. Human pulmonary fibroblasts exhibit altered interleukin-4 and interleukin-13 receptor subunit expression in idiopathic interstitial pneumonia. Am J Pathol. 2004 Jun;164(6):1989-2001.

10660.  Oldfield C, Bonella H, Renwick L, Dodson HI, Alderson G, Goodfellow M.  Rapid determination of vapA/vapB genotype in Rhodococcus equi using a differential polymerase chain reaction method. Antonie Van Leeuwenhoek. 2004 May;85(4):317-26.

10661.                        Zar HJ. Pneumonia in HIV-infected and HIV-uninfected children in developing countries: epidemiology, clinical features, and management. Curr Opin Pulm Med. 2004 May;10(3):176-82. Review.

Vaccines:

10662.  Bosompra K, Ashikaga T, Ruby A. Attitudes, perceived norms, and intentions: a needs assessment study of the influenza immunization intentions of elderly citizens in Vermont. J Rural Health. 2004 Spring;20(2):125-30.

10663.  Quinley JC, Shih A. Improving physician coverage of pneumococcal vaccine: a randomized trial of a telephone intervention. J Community Health. 2004 Apr;29(2):103-15.

Therapy:

10664.  Agarwal G, Awasthi S, Kabra SK, Kaul A, Singhi S, Walter SD; ISCAP Study Group. Three day versus five-day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial. BMJ. 2004 Apr 3;328(7443):791.

10665.  Brooks WA, Yunus M, Santosham M, Wahed MA, Nahar K, Yeasmin S, Black RE. Zinc for severe pneumonia in very young children: double-blind placebo-controlled trial. Lancet. 2004 May 22;363(9422):1683-8.

10666.  Buising KL, Thursky KA, Black JF, Brown GV. Are the Australian guidelines asking too much of the Pneumonia Severity Index (PSI)? Med J Aust. 2004 May 3;180(9):486-7.

10667.  Feldman C. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia. J Lab Clin Med. 2004 May;143(5):269-83. Review.

10668.  File TM Jr. Shorter course therapy of serious respiratory infections: new data for new approaches to management. Curr Opin Infect Dis. 2004 Apr;17(2):105-7. Review.

10669.  Gozum S, Unsal A. Use of herbal therapies by older, community-dwelling women. J Adv Nurs. 2004 Apr;46(2):171-8.

10670.  Loeb M. Pneumonia in the elderly. Curr Opin Infect Dis. 2004 Apr;17(2):127-30. Review.

10671.  Low DE. Quinolone resistance among pneumococci: therapeutic and diagnostic implications. Clin Infect Dis. 2004 May 15;38 Suppl 4:S357-62.

10672.  Macfarlane JT, Boldy D. 2004 update of BTS pneumonia guidelines: what's new? Thorax. 2004 May;59(5):364-6.

10673.  Martinez FJ. Monotherapy versus dual therapy for community-acquired pneumonia in hospitalized patients. Clin Infect Dis. 2004 May 15;38 Suppl 4:S328-40.